Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study

Mark Crowther, MD, David A. Garcia, MD, Jason Hill, MDMSc, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141850

Published: 2020

Journal Articles

High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment

Kylee L Martens, MD, Wilson L da Costa, Jr., MD MPH, PhD, Chris Davis, M.S., Madeline Kesten, Stephanie J. Lee, MDMPH, Neil A. Zakai, MDMSc, David A. Garcia, MD, Ang Li, MDMS

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-134952

Published: 2020

Journal Articles

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

Andrew J. Cowan, MD, Shasank R Chennupati, PharmD, MPH, Yuan Xu, PhD, Ang Li, MDMS, David A. Garcia, MD, Edward Libby, MD, Catherine Fedorenko, MMSci, Scott D Ramsey, MD PhD, Veena Shankaran, MD, Winson Y Cheung, MDMPH

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141088

Published: 2020

Journal Articles

D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation

Ang Li, MD, Qian Vicky Wu, PhD, Gary Schoch, Madeline Kesten, Emily Pao, MS, Jingfei Dong, MD PhD, David A. Garcia, MD, Sangeeta R Hingorani, MD MPH

Blood (2019) 134 (Supplement_1): 3645.

https://doi.org/10.1182/blood-2019-127862

Published: 2019

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia

Kylee L Martens, MD, Parisa R Khalighi, BS, Shan Li, PharmD, Andrew A White, MD, Emily Silgard, MS, Deborah Frieze, PharmD, Elihu H. Estey, MD, David A. Garcia, MD, Sangeeta R Hingorani, MD MPH, Ang Li, MD

Blood (2019) 134 (Supplement_1): 4674.

https://doi.org/10.1182/blood-2019-124058

Published: 2019

Journal Articles

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

Thita Chiasakul, MD MSc, Elizabeth De Jesus, Jiayi Tong, B.S., Yong Chen, PhD, Mark Crowther, MD, David A. Garcia, MD, Chatree Chai-Adisaksopha, MD, Steven R. Messé, MD, Adam Cuker, MD MS

Blood (2018) 132 (Supplement 1): 2518.

https://doi.org/10.1182/blood-2018-99-110997

Published: 2018

Journal Articles

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 361.

https://doi.org/10.1182/blood-2018-99-110500

Published: 2018

Journal Articles

The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study

Deepti M. Warad, MD, Bethany T Samuelson Bannow, MD, Curtis Jones, BS, Shannon Pechauer, Brian R. Curtis, PhD, Daniel W. Bougie, PhD, Parisa R Khalighi, BS, Diane E. Grill, MS, Rachel Leger, BAE, Ruchika Sharma, MD, Dong Chen, MD PhD, Richard H. Aster, MD, David A. Garcia, MD, Anand Padmanabhan, MD PhD

Blood (2018) 132 (Supplement 1): 416.

https://doi.org/10.1182/blood-2018-99-112475

Published: 2018

Journal Articles

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Neil A Zakai, MD MSc, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 144.

https://doi.org/10.1182/blood-2018-99-110567

Published: 2018

Journal Articles

The Association between Transplant-Associated Thrombotic Microangiopathy and Calcineurin Inhibitor and Sirolimus Levels

Ang Li, MD, Qian V. Wu, PhD, Chris Davis, Stephanie J. Lee, MD MPH, Jingfei Dong, MD PhD, David A. Garcia, MD, Sangeeta Hingorani, MD MPH

Blood (2018) 132 (Supplement 1): 814.

https://doi.org/10.1182/blood-2018-99-110400

Published: 2018

Journal Articles

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Nicholas Burwick, MD, Jacob Stein, David A Garcia, MD, Virginia C. Broudy, MD, Robert E. Richard, MD PhD

Blood (2017) 130 (Supplement 1): 673.

https://doi.org/10.1182/blood.V130.Suppl_1.673.673

Published: 2017

Journal Articles

Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Not a Singular Entity

Ang Li, MD, Chris Davis, Phuqui D Pham, Qian Wu, PhD, Stephanie J Lee, MD MPH, Ajay K. Gopal, MD, Jingfei Dong, MD PhD, David A Garcia, MD, Sangeeta Hingorani, MD MPH

Blood (2017) 130 (Supplement 1): 666.

https://doi.org/10.1182/blood.V130.Suppl_1.666.666

Published: 2017

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

External Validation of the Plasmic Score: A Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura (TTP) Diagnosis and Treatment

Parisa R Khalighi, BS, Qian Wu, PhD, David A Garcia, MD, Ang Li, MD

Blood (2017) 130 (Supplement 1): 3646.

https://doi.org/10.1182/blood.V130.Suppl_1.3646.3646

Published: 2017

Journal Articles

HIT Diagnosis: A Proposed New Definition for Clinical Research

Parisa R Khalighi, BS, David A Garcia, MD, Anand Padmanabhan, MD PhD, Bethany T Samuelson Bannow, MD

Blood (2017) 130 (Supplement 1): 3621.

https://doi.org/10.1182/blood.V130.Suppl_1.3621.3621

Published: 2017

Journal Articles

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

Blood (2017) 130 (Supplement 1): 626.

https://doi.org/10.1182/blood.V130.Suppl_1.626.626

Published: 2017

Journal Articles

The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis

Blood (2017) 130 (Supplement 1): 627.

https://doi.org/10.1182/blood.V130.Suppl_1.627.627

Published: 2017

Journal Articles

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Bethany T Samuelson, MD, Roland B. Walter, MD PhD, Terry Gernsheimer, MD, David A Garcia, MD

Blood (2016) 128 (22): 164.

https://doi.org/10.1182/blood.V128.22.164.164

Published: 2016

Journal Articles

Management of Anticoagulation in Patients with Hematologic Malignancy Undergoing Autologous Hematopoietic Cell Transplantation

Ang Li, MD, Chris Davis, Qian Wu, Madeline F Kesten, Ajay K Gopal, MD, David A Garcia, MD

Blood (2016) 128 (22): 1437.

https://doi.org/10.1182/blood.V128.22.1437.1437

Published: 2016

NARROW

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study

High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

The Association between Transplant-Associated Thrombotic Microangiopathy and Calcineurin Inhibitor and Sirolimus Levels

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Not a Singular Entity

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

External Validation of the Plasmic Score: A Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura (TTP) Diagnosis and Treatment

HIT Diagnosis: A Proposed New Definition for Clinical Research

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Management of Anticoagulation in Patients with Hematologic Malignancy Undergoing Autologous Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only